ArticleJournal of Korean medical science2020
Years of Life Lost Attributable to COVID-19 in High-incidence Countries.
Article in Journal of Korean medical science, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 5 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
26 citing papers in PubMed, 5 syntheses or guidelines pooled it.
- Integrated Clinical and Social Impacts of the COVID-19 Pandemic in Korea: A Combined Systematic and Narrative Review.Journal of Korean medical science · 2026Pooled it
- The burden of COVID-19 based on disability-adjusted life years: a systematic review of available evidence.Frontiers in public health · 2025Pooled it
- Disability-adjusted life years (DALYs) based COVID-19 health impact assessment: a systematic review.BMC public health · 2023Pooled it
- Economic evaluation of COVID-19 vaccination: A systematic review.Journal of global health · 2023Pooled it
- Economic evaluation of programs against COVID-19: A systematic review.International journal of surgery (London, England) · 2021Pooled it
- The impact of COVID-19: consequences of a 3-Year struggle in Iran.BMC infectious diseases · 2025Article
- Designing a model to estimate the burden of COVID-19 in Iran.BMC public health · 2024Article
- Age and sex differences in cause-specific excess mortality and years of life lost associated with COVID-19 infection in the Swedish population.European journal of public health · 2023Observational
- Updating Korean Disability Weights for Causes of Disease: Adopting an Add-on Study Method.Journal of preventive medicine and public health = Yebang Uihakhoe chi · 2023Article
- Economic evaluation of strategies against coronavirus: a systematic review.Health economics review · 2023Review
- Years of life lost (YLL) associated with COVID-19 deaths in Khorasan-RAZAVI province, Iran.Journal of public health (Oxford, England) · 2023Article
- Burden of COVID-19 disease in Kurdistan province in west of Iran using disability-adjusted life years.Health science reports · 2023Article
- Years of life lost to COVID-19 in 49 countries: A gender- and life cycle-based analysis of the first two years of the pandemic.PLOS global public health · 2023Article
- Is Mandatory Vaccination in Population over 60 Adequate to Control the COVID-19 Pandemic in E.U.?Vaccines · 2022Article
- Disability-adjusted life years (DALYs) due to the direct health impact of COVID-19 in India, 2020.Scientific reports · 2022Article
- Premature mortality attributable to COVID-19: potential years of life lost in 17 countries around the world, January-August 2020.BMC public health · 2022Article
- Disability-adjusted life years (DALYs) based COVID-19 health impact assessment: A systematic review protocol.PloS one · 2022Article
- Decrease in life expectancy due to COVID-19 disease not offset by reduced environmental impacts associated with lockdowns in Italy.Environmental pollution (Barking, Essex : 1987) · 2022Article
- Impact of COVID-19 on care-home mortality and life expectancy in Scotland.Age and ageing · 2021Article
- Years of life lost by COVID-19 in Portugal and comparison with other European countries in 2020.BMC public health · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundThe coronavirus disease 2019 (COVID-19) pandemic is a major public health problem of international concern. It is important to estimate its impact of COVID-19 for health policy decision-making. We estimated the years of life lost (YLLs) due to COVID-19 in high-incidence countries.
methodsWe collected the YLLs due to COVID-19 in 30 high-incidence countries as of April 13, 2020 and followed up as of July 14, 2020. Incidence and mortality were collected using each country's formal reports, articles, and other electronic sources. The life expectancy of Japanese females by age and the UN population data were used to calculate YLLs in total and per 100,000.
resultsAs of April 22, 2020, there were 1,699,574 YLLs due to COVID-19 in 30 high-incidence countries. On July 14, 2020, this increased to 4,072,325. Both on April 22 and July 14, the total YLLs due to COVID-19 was highest in the USA (April 22, 534,481 YLLs; July 14, 1,199,510 YLLs), and the YLLs per 100,000 population was highest in Belgium (April 22, 868.12 YLLs/100,000; July 14, 1,593.72 YLLs/100,000). YLLs due to COVID-19 were higher among males than among females and higher in those aged ≥ 60 years than in younger individuals. Belgium had the highest proportion of YLLs attributable to COVID-19 as a proportion of the total YLLs and the highest disability-adjusted life years per 100,000 population.
conclusionThis study estimated YLLs due to COVID-19 in 30 countries. COVID-19 is a high burden in the USA and Belgium, among males and the elderly. The YLLs are very closely related with the incidence as well as the mortality. This highlights the importance of the early detection of incident case that minimizes severe acute respiratory syndrome coronavirus-2 fatality.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.